Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Clinical trial NCT04072835 · COMPLETED
Trial details
- NCT number
- NCT04072835
- Sponsor
- Milestone Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-23
- Primary completion
- 2023-01-26
- Enrollment
- 1116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.